X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (46558) 46558
Book Review (9240) 9240
Newspaper Article (4506) 4506
Publication (3104) 3104
Newsletter (2596) 2596
Magazine Article (472) 472
Book Chapter (392) 392
Trade Publication Article (269) 269
Book / eBook (240) 240
Conference Proceeding (78) 78
Dissertation (65) 65
Web Resource (63) 63
Government Document (55) 55
Transcript (42) 42
Reference (19) 19
Report (15) 15
Data Set (7) 7
Paper (5) 5
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35027) 35027
antibiotics (34700) 34700
humans (27800) 27800
female (13075) 13075
male (11743) 11743
infections (9318) 9318
microbiology (8678) 8678
infectious diseases (8554) 8554
bacteria (8225) 8225
anti-bacterial agents - therapeutic use (8178) 8178
middle aged (7664) 7664
animals (7596) 7596
adult (7490) 7490
research (6859) 6859
health aspects (6839) 6839
drug resistance (6784) 6784
pharmacology & pharmacy (6506) 6506
aged (6130) 6130
anti-bacterial agents - pharmacology (5388) 5388
infection (4824) 4824
treatment outcome (4786) 4786
analysis (4782) 4782
drug therapy (4734) 4734
care and treatment (4730) 4730
drug resistance in microorganisms (4500) 4500
antimicrobial agents (4445) 4445
microbial sensitivity tests (4390) 4390
mortality (4193) 4193
patients (4189) 4189
risk factors (4101) 4101
drug therapy, combination (3914) 3914
medicine (3870) 3870
bacterial infections (3776) 3776
therapy (3736) 3736
surgery (3697) 3697
studies (3594) 3594
abridged index medicus (3480) 3480
anti-bacterial agents - administration & dosage (3447) 3447
antibiotic resistance (3429) 3429
cancer (3365) 3365
chemotherapy (3334) 3334
oncology (3324) 3324
hospitals (3295) 3295
adolescent (3222) 3222
research article (3122) 3122
pneumonia (2997) 2997
medical research (2918) 2918
resistance (2906) 2906
drugs (2904) 2904
child (2899) 2899
retrospective studies (2868) 2868
diagnosis (2866) 2866
antibiotic-resistance (2857) 2857
epidemiology (2836) 2836
pathogens (2823) 2823
immunology (2812) 2812
mice (2812) 2812
usage (2603) 2603
management (2577) 2577
aged, 80 and over (2498) 2498
children (2459) 2459
dosage and administration (2418) 2418
pediatrics (2396) 2396
multidisciplinary sciences (2388) 2388
antimicrobial resistance (2371) 2371
medicine, general & internal (2273) 2273
escherichia-coli (2266) 2266
clinical trials (2249) 2249
drug resistance, bacterial (2240) 2240
medicine & public health (2213) 2213
antibacterial agents (2199) 2199
prospective studies (2184) 2184
child, preschool (2140) 2140
proteins (2139) 2139
antibiotics, antineoplastic - administration & dosage (2130) 2130
prevention (2092) 2092
staphylococcus infections (2064) 2064
disease (2060) 2060
science (2010) 2010
laboratories (1981) 1981
in-vitro (1954) 1954
sepsis (1941) 1941
antibiotics, antineoplastic - therapeutic use (1918) 1918
nosocomial infections (1918) 1918
infant (1851) 1851
medicine, experimental (1832) 1832
time factors (1810) 1810
internal medicine (1779) 1779
gram-negative bacteria (1758) 1758
young adult (1756) 1756
antibiotic prophylaxis (1729) 1729
antibiotics, antineoplastic - pharmacology (1725) 1725
pharmacology (1710) 1710
staphylococcus aureus (1710) 1710
e coli (1680) 1680
pseudomonas-aeruginosa (1672) 1672
biofilms (1667) 1667
tuberculosis (1626) 1626
article (1624) 1624
drug dosages (1621) 1621
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (156) 156
UTL at Downsview - May be requested (12) 12
UofT at Scarborough - Stacks (9) 9
UofT at Mississauga - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Online Resources - Online (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Chemistry (A D Allen) - Stacks (4) 4
St. Michael's Hospital - Stacks (3) 3
Dentistry (Harry R Abbott) - Withdrawn (2) 2
Earth Sciences (Noranda) - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
Media Commons - Microtexts (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (53962) 53962
French (363) 363
German (271) 271
Japanese (174) 174
Russian (131) 131
Spanish (123) 123
Italian (29) 29
Chinese (28) 28
Turkish (28) 28
Polish (19) 19
Korean (13) 13
Dutch (11) 11
Portuguese (11) 11
Hungarian (10) 10
Croatian (7) 7
Czech (7) 7
Bulgarian (6) 6
Danish (4) 4
Lithuanian (4) 4
Norwegian (4) 4
Swedish (4) 4
Ukrainian (4) 4
Romanian (3) 3
Slovenian (3) 3
Finnish (2) 2
Latvian (2) 2
Serbian (2) 2
Slovak (2) 2
Urdu (2) 2
Indonesian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 7, pp. 677 - 678
Journal Article
Pediatrics, ISSN 0031-4005, 2014, Volume 133, Issue 5, pp. e1148 - e1155
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2015, Volume 12, Issue 2, pp. 387 - 397
Abstract Though combination chemotherapy or antitumor nanomedicine is extensively investigated, their combining remains in infancy. Additionally, enhanced... 
Internal Medicine | Luminal A breast cancer | Tamoxifen | Doxorubicin | Penta-peptide QLPVM | Nanomedicine based combinational therapy | KU70 | MEDICINE, RESEARCH & EXPERIMENTAL | EFFICACY | SUBTYPES | NANOSCIENCE & NANOTECHNOLOGY | CELL-PENETRATING PEPTIDES | RELEASE | TUMORS | DELIVERY | NANOPARTICLES | BIOLOGY | Doxorubicin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Breast - metabolism | Polyethylene Glycols - therapeutic use | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Antineoplastic Agents, Hormonal - therapeutic use | Doxorubicin - analogs & derivatives | Female | Breast - pathology | Nanomedicine | Oligopeptides - chemistry | Cell-Penetrating Peptides - chemistry | Doxorubicin - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Ku Autoantigen - chemistry | bcl-2-Associated X Protein - metabolism | Ku Autoantigen - metabolism | Oligopeptides - metabolism | Breast Neoplasms - drug therapy | Polyethylene Glycols - administration & dosage | Antibiotics, Antineoplastic - administration & dosage | Liposomes - chemistry | Animals | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast - drug effects | Breast Neoplasms - pathology | Mice, Nude | Tamoxifen - therapeutic use | Cell Line, Tumor | Liposomes - metabolism | Drug Combinations | Cell-Penetrating Peptides - metabolism | Chemotherapy | Anthracyclines | Peptides | Estrogen | Breast cancer | Drug therapy, Combination | Cancer | Index Medicus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 7, pp. 726 - 734
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 06/2015, Volume 207, pp. 77 - 85
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 07/2017, Volume 258, pp. 43 - 55
Two novel prodrug polymers POEG- -PSSDas (redox-sensitive) and POEG- -PCCDas (redox-insensitive), which consist of poly(oligo(ethylene glycol) methacrylate)... 
Prodrug micelles | Dasatinib | Redox responsive | Co-delivery | Doxorubicin | DESIGN | DRUG-DELIVERY | OVARIAN-CANCER | ANTITUMOR-ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | CHRONIC MYELOID-LEUKEMIA | PACLITAXEL | BREAST-CANCER CELLS | FAMILY KINASE INHIBITOR | IMATINIB | PHARMACOLOGY & PHARMACY | MULTIDRUG-RESISTANCE | Prodrugs - administration & dosage | Doxorubicin - therapeutic use | Humans | Dasatinib - pharmacokinetics | Delayed-Action Preparations - chemistry | Polyethylene Glycols - chemistry | Drug Delivery Systems | Micelles | Female | Antibiotics, Antineoplastic - pharmacokinetics | Doxorubicin - administration & dosage | Protein Kinase Inhibitors - pharmacokinetics | Cell Survival - drug effects | Oxidation-Reduction | Dasatinib - therapeutic use | Doxorubicin - pharmacokinetics | Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Animals | Dasatinib - administration & dosage | Antibiotics, Antineoplastic - therapeutic use | Prodrugs - pharmacokinetics | Protein Kinase Inhibitors - therapeutic use | Cell Line, Tumor | Mice, Inbred BALB C | Prodrugs - therapeutic use | Neoplasms - pathology | Ethylene glycol | Anthracyclines | Chemotherapy | Polymers | Analysis | Cancer | Tyrosine | Medical colleges | Pharmacogenetics | Pharmacy | Physiological aspects | Drugstores | Index Medicus | co-delivery | dasatinib | doxorubicin | prodrug micelles | redox responsive
Journal Article
Gut, ISSN 0017-5749, 02/2018, Volume 67, Issue 2, pp. 320 - 332
ObjectiveLimited efficacy of immune checkpoint inhibitors in pancreatic ductal adenocarcinoma (PDAC) has prompted investigation into combination therapy. We... 
INTERLEUKINS | IMMUNOTHERAPY | PANCREATIC CANCER | MULTIPLE-MYELOMA | INTERFERON-ALPHA | ACTIVATION | ADENOCARCINOMA | SILTUXIMAB | MONOCLONAL-ANTIBODY | MICE | SUPPRESSOR-CELLS | INTERLEUKIN-6 | GASTROENTEROLOGY & HEPATOLOGY | T-CELLS | Antineoplastic Agents, Immunological - administration & dosage | Interleukin-6 - antagonists & inhibitors | Pancreatic Neoplasms - metabolism | Humans | Actins - metabolism | Carcinoma, Pancreatic Ductal - metabolism | STAT Transcription Factors - metabolism | Janus Kinases - metabolism | L-Selectin - metabolism | Pancreatic Neoplasms - drug therapy | Th1 Cells - metabolism | Pancreatic Stellate Cells - immunology | Hyaluronan Receptors - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Carcinoma, Pancreatic Ductal - immunology | Interleukin-6 - metabolism | Disease Models, Animal | Mice, Inbred C57BL | Survival Rate | B7-H1 Antigen - immunology | Disease Progression | Tumor Microenvironment - immunology | Xenograft Model Antitumor Assays | Carcinoma, Pancreatic Ductal - drug therapy | B7-H1 Antigen - metabolism | Animals | B7-H1 Antigen - antagonists & inhibitors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pancreatic Neoplasms - immunology | Interleukin-6 - immunology | Mice | Pancreatic Stellate Cells - metabolism | Adenocarcinoma | Immunohistochemistry | Flow cytometry | Animal models | Transcription | CD8 antigen | Multiple myeloma | Smooth muscle | Lymphocytes T | Kinases | Metastases | Interleukin 6 | Lymphocytes | Actin | CD44 antigen | Immunotherapy | Fibroblasts | BRCA2 protein | Stellate cells | Cytokines | Secretion | Stroma | CD62L protein | CD4 antigen | Immune checkpoint | Antibiotics | Pancreatic cancer | Medical prognosis | PD-L1 protein | Cell lines | Ligands | Genetic engineering | Apoptosis | Index Medicus | Abridged Index Medicus | PD-L1 | pancreatic cancer | IL-6
Journal Article